Skip to main content

Institutional intelligence for GKB Ophthalmics Ltd

Cross-view mutual fund activity and super-investor shareholding · Jun 2026 SHP.

Tracked super investors holding ≥1%

Ownership breakdown

Estimated from named holders at or above 1% in the latest filing (Jun 2026). Official category totals not yet parsed. Sums to 76.04%.

  • Promoters51.14%
  • FII5.76%
  • Retail & others (est.)19.14%
  • Super Investors 1.21%(subset)
  • 1% Club 22.75%(subset)

Super Investors and 1% Club names below are disclosed holders at or above 1%. They are subsets of the categories above, not additive.

Holder details (≥1% disclosed names)

1% Club — Individuals & others

Non-promoter ≥1% holders not matched to a curated profile

22.75%10 named
HolderStakeSharesValue (₹ Cr)
5.54%2,79,293₹1.8 Cr
4.82%2,43,049₹1.5 Cr
3.31%1,67,044₹1.0 Cr
1.80%90,627₹57.0 L
1.40%70,500₹44.0 L
1.32%66,667₹42.0 L
1.27%63,886₹40.0 L
1.26%63,305₹40.0 L
1.02%51,503₹32.0 L
1.01%51,000₹32.0 L

Promoters

Promoter & promoter group

6 named
HolderStakeSharesValue (₹ Cr)
17.91%9,02,812₹5.6 Cr
8.39%4,23,105₹2.6 Cr
8.09%4,07,966₹2.5 Cr
5.97%3,01,069₹1.9 Cr
5.97%3,00,753₹1.9 Cr
4.81%2,42,464₹1.5 Cr

FII / FPI

Foreign portfolio investors

2 named
HolderStakeSharesValue (₹ Cr)
3.97%2,00,000₹1.3 Cr
1.79%90,000₹56.0 L

Super Investors

Curated tracked investor profiles

1.21%1 named
HolderStakeSharesValue (₹ Cr)
Tracked as Mahendra Girdharilal1.21%61,242₹38.0 L

DII (other)

Insurance, banks, AIF, other domestic institutions

No names

No named holders ≥1% in this bucket.

Mutual Funds

Domestic mutual funds & UTI

No names

No named holders ≥1% in this bucket.

Retail & others

Holders below 1% disclosure threshold and public non-institutions

SEBI requires naming only shareholders with ≥1% stake. The remaining includes retail investors, small HNIs, employee trusts, and other holders below the disclosure threshold — aggregated in the official filing.

Shareholding data sourced from NSE/BSE regulatory filings. Category chart uses official filing totals; named holder lists include every disclosed ≥1% position. Not investment advice. See our disclaimer and methodology.